Comparison between levofluxain and clarithromycin treatment in helicobacter pylori eradicatio

Phase 1

• Conditions: Helicobacter pylori.; Diseases of oesophagus, stomach and duodenum; K20-K31

• Registration Number: IRCT2015030421328N1
• Lead Sponsor: Vice-chancellor Of Research, Daneshgah Square, Ganjafrooz Avenue

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

complaint of dyspepsia
Exclusion criteria:using ppi or h2b during recent 4weeks,past history of gastric surgery,past history of gastric cancer,pregnancy,comorbid diseases.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eradication rate of helicobacter pylori. Timepoint: 4 weeks after the end of the intervention. Method of measurement: Stool Ag.

Secondary Outcome Measures

Name	Time	Method
Eradication rate of HP in male and female. Timepoint: 4 weeks after intervention. Method of measurement: Stool Ag.;Endoscopic findings. Timepoint: Before the intervention. Method of measurement: Endoscopic.